Srikanth Ambati, MD, MBBS

Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY
USA Papers:
1690 Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti‑CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Other B-Cell Non-Hodgkin Lymphoma (B-NHL) Subtypes